Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000174

EVP, Chief Technical Ops. Off. sold 7,288 shares at $478.00 ($3,483,664)

  • EVP, Chief Technical Ops. Off. gave up 6,824 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-11 Shares withheld for taxes : show line 1 in the form 10b5-1 −6,824 $481.96 $3,288,895 23,260 D
2024-06-12 Sale : show line 2 in the form 10b5-1 −7,288 $478.00 $3,483,664 15,972 D
Open-market sales · 7,288 sh · avg $478.00 · $3,483,664
Loading xslF345X05/wk-form4_1718309345.xml…